HEADER TRANSFERASE 29-AUG-08 2JKQ TITLE FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS-ANILINO TITLE 2 PYRIMIDINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: FOCAL ADHESION KINASE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 411-686; COMPND 5 SYNONYM: FOCAL ADHESION KINASE, FADK 1; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: CHICKEN; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: HIGH FIVE; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PACG2T KEYWDS TRANSFERASE, NUCLEOTIDE-BINDING, TYROSINE-PROTEIN KINASE, KINASE KEYWDS 2 INHIBITOR, INTEGRIN SIGNALING, KINASE, ATP-BINDING, CELL MIGRATION, KEYWDS 3 FOCAL ADHESION EXPDTA X-RAY DIFFRACTION AUTHOR D.LIETHA,M.J.ECK REVDAT 5 13-DEC-23 2JKQ 1 REMARK REVDAT 4 03-APR-19 2JKQ 1 SOURCE REVDAT 3 13-JUL-11 2JKQ 1 VERSN REVDAT 2 09-DEC-08 2JKQ 1 VERSN JRNL REVDAT 1 09-SEP-08 2JKQ 0 JRNL AUTH D.LIETHA,M.J.ECK JRNL TITL CRYSTAL STRUCTURES OF THE FAK KINASE IN COMPLEX WITH TAE226 JRNL TITL 2 AND RELATED BIS-ANILINO PYRIMIDINE INHIBITORS REVEAL A JRNL TITL 3 HELICAL DFG CONFORMATION. JRNL REF PLOS ONE V. 3 E3800 2008 JRNL REFN ESSN 1932-6203 JRNL PMID 19030106 JRNL DOI 10.1371/JOURNAL.PONE.0003800 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.08 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 92.1 REMARK 3 NUMBER OF REFLECTIONS : 7222 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.500 REMARK 3 FREE R VALUE TEST SET COUNT : 339 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 356 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2680 REMARK 3 BIN FREE R VALUE SET COUNT : 12 REMARK 3 BIN FREE R VALUE : 0.4480 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2064 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 24 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.20000 REMARK 3 B22 (A**2) : 0.07000 REMARK 3 B33 (A**2) : -0.49000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.19000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.386 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.308 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 29.494 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.924 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.872 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2156 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2920 ; 1.295 ; 1.987 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 256 ; 7.540 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 95 ;35.361 ;23.368 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 377 ;16.516 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;20.409 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 317 ; 0.085 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1619 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 948 ; 0.208 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1480 ; 0.308 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 66 ; 0.174 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 46 ; 0.240 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 2 ; 0.165 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1339 ; 0.579 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2086 ; 0.610 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 955 ; 1.152 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 834 ; 1.743 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 414 A 503 REMARK 3 ORIGIN FOR THE GROUP (A): 5.8670 13.5010 28.4630 REMARK 3 T TENSOR REMARK 3 T11: 0.0482 T22: -0.0814 REMARK 3 T33: 0.1737 T12: 0.0170 REMARK 3 T13: 0.2355 T23: 0.0368 REMARK 3 L TENSOR REMARK 3 L11: 3.1400 L22: 3.5995 REMARK 3 L33: 7.2593 L12: -0.9005 REMARK 3 L13: -0.9774 L23: 1.6769 REMARK 3 S TENSOR REMARK 3 S11: 0.1773 S12: 0.0566 S13: 0.3509 REMARK 3 S21: 0.2581 S22: -0.0464 S23: -0.0087 REMARK 3 S31: -0.4021 S32: 0.4842 S33: -0.1308 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 504 A 686 REMARK 3 ORIGIN FOR THE GROUP (A): 12.6430 -5.3570 10.0140 REMARK 3 T TENSOR REMARK 3 T11: -0.1266 T22: -0.0602 REMARK 3 T33: 0.0333 T12: 0.0225 REMARK 3 T13: 0.1555 T23: -0.0391 REMARK 3 L TENSOR REMARK 3 L11: 3.7235 L22: 3.8441 REMARK 3 L33: 3.5398 L12: -0.1190 REMARK 3 L13: -1.7210 L23: 0.0028 REMARK 3 S TENSOR REMARK 3 S11: -0.0133 S12: 0.1645 S13: -0.1066 REMARK 3 S21: -0.1994 S22: -0.0064 S23: -0.1908 REMARK 3 S31: -0.0350 S32: -0.0455 S33: 0.0197 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2JKQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-AUG-08. REMARK 100 THE DEPOSITION ID IS D_1290037355. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7576 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.1 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.18000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 63.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.29000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.080 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1MP8 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 31% PEG4000, 0.1 M TRIS PH 8.5, 10 MM REMARK 280 TCEP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 22.44350 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 411 REMARK 465 THR A 412 REMARK 465 ARG A 413 REMARK 465 ARG A 569 REMARK 465 TYR A 570 REMARK 465 MET A 571 REMARK 465 GLU A 572 REMARK 465 ASP A 573 REMARK 465 SER A 574 REMARK 465 THR A 575 REMARK 465 TYR A 576 REMARK 465 TYR A 577 REMARK 465 LYS A 578 REMARK 465 ALA A 579 REMARK 465 SER A 580 REMARK 465 LYS A 581 REMARK 465 GLY A 582 REMARK 465 LYS A 583 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 414 CG OD1 OD2 REMARK 470 LEU A 584 CG CD1 CD2 REMARK 470 LEU A 685 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 445 CD GLU A 445 OE1 0.217 REMARK 500 GLU A 445 C ASN A 446 N 0.199 REMARK 500 ASN A 446 CB ASN A 446 CG 0.207 REMARK 500 ASN A 446 CG ASN A 446 ND2 0.177 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU A 445 OE1 - CD - OE2 ANGL. DEV. = 10.3 DEGREES REMARK 500 ASN A 446 CA - CB - CG ANGL. DEV. = -13.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 445 -92.80 136.63 REMARK 500 ASN A 446 106.02 53.51 REMARK 500 PRO A 447 -91.18 -73.63 REMARK 500 ALA A 448 123.81 174.41 REMARK 500 CYS A 459 8.49 -63.92 REMARK 500 ARG A 514 34.01 -91.13 REMARK 500 ARG A 545 -12.92 77.77 REMARK 500 ARG A 597 19.94 50.35 REMARK 500 ASN A 646 -2.97 69.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU A 445 ASN A 446 77.29 REMARK 500 PRO A 447 ALA A 448 -144.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VG8 A 1687 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1KTM RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF FAT DOMAIN OF FOCAL ADHESION KINASE REMARK 900 RELATED ID: 2JKK RELATED DB: PDB REMARK 900 FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS-ANILINO REMARK 900 PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 2J0K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A FRAGMENT OF FOCAL ADHESION KINASE CONTAINING REMARK 900 THE FERM AND KINASE DOMAINS. REMARK 900 RELATED ID: 1PV3 RELATED DB: PDB REMARK 900 NMR SOLUTION STRUCTURE OF THE AVIAN FAT- DOMAIN OF FOCALADHESION REMARK 900 KINASE REMARK 900 RELATED ID: 2J0L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A THE ACTIVE CONFORMATION OF THE KINASE DOMAIN REMARK 900 OF FOCAL ADHESION KINASE WITH A PHOSPHORYLATED ACTIVATION LOOP. REMARK 900 RELATED ID: 2JKO RELATED DB: PDB REMARK 900 FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS-ANILINO REMARK 900 PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 2J0M RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE A TWO-CHAIN COMPLEX BETWEEN THE FERM AND KINASE REMARK 900 DOMAINS OF FOCAL ADHESION KINASE. REMARK 900 RELATED ID: 2J0J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A FRAGMENT OF FOCAL ADHESION KINASE CONTAINING REMARK 900 THE FERM AND KINASE DOMAINS. REMARK 900 RELATED ID: 2JKM RELATED DB: PDB REMARK 900 FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS-ANILINO REMARK 900 PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 2AL6 RELATED DB: PDB REMARK 900 FERM DOMAIN OF FOCAL ADHESION KINASE REMARK 900 RELATED ID: 1QVX RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE FAT DOMAIN OF FOCAL ADHESIONKINASE REMARK 900 RELATED ID: 2AEH RELATED DB: PDB REMARK 900 FOCAL ADHESION KINASE 1 DBREF 2JKQ A 411 686 UNP Q00944 FAK1_CHICK 411 686 SEQADV 2JKQ LEU A 449 UNP Q00944 MET 449 CONFLICT SEQADV 2JKQ TYR A 516 UNP Q00944 PHE 516 CONFLICT SEQADV 2JKQ SER A 556 UNP Q00944 ALA 556 CONFLICT SEQADV 2JKQ ASN A 557 UNP Q00944 THR 557 CONFLICT SEQRES 1 A 276 SER THR ARG ASP TYR GLU ILE GLN ARG GLU ARG ILE GLU SEQRES 2 A 276 LEU GLY ARG CYS ILE GLY GLU GLY GLN PHE GLY ASP VAL SEQRES 3 A 276 HIS GLN GLY ILE TYR MET SER PRO GLU ASN PRO ALA LEU SEQRES 4 A 276 ALA VAL ALA ILE LYS THR CYS LYS ASN CYS THR SER ASP SEQRES 5 A 276 SER VAL ARG GLU LYS PHE LEU GLN GLU ALA LEU THR MET SEQRES 6 A 276 ARG GLN PHE ASP HIS PRO HIS ILE VAL LYS LEU ILE GLY SEQRES 7 A 276 VAL ILE THR GLU ASN PRO VAL TRP ILE ILE MET GLU LEU SEQRES 8 A 276 CYS THR LEU GLY GLU LEU ARG SER PHE LEU GLN VAL ARG SEQRES 9 A 276 LYS TYR SER LEU ASP LEU ALA SER LEU ILE LEU TYR ALA SEQRES 10 A 276 TYR GLN LEU SER THR ALA LEU ALA TYR LEU GLU SER LYS SEQRES 11 A 276 ARG PHE VAL HIS ARG ASP ILE ALA ALA ARG ASN VAL LEU SEQRES 12 A 276 VAL SER SER ASN ASP CYS VAL LYS LEU GLY ASP PHE GLY SEQRES 13 A 276 LEU SER ARG TYR MET GLU ASP SER THR TYR TYR LYS ALA SEQRES 14 A 276 SER LYS GLY LYS LEU PRO ILE LYS TRP MET ALA PRO GLU SEQRES 15 A 276 SER ILE ASN PHE ARG ARG PHE THR SER ALA SER ASP VAL SEQRES 16 A 276 TRP MET PHE GLY VAL CYS MET TRP GLU ILE LEU MET HIS SEQRES 17 A 276 GLY VAL LYS PRO PHE GLN GLY VAL LYS ASN ASN ASP VAL SEQRES 18 A 276 ILE GLY ARG ILE GLU ASN GLY GLU ARG LEU PRO MET PRO SEQRES 19 A 276 PRO ASN CYS PRO PRO THR LEU TYR SER LEU MET THR LYS SEQRES 20 A 276 CYS TRP ALA TYR ASP PRO SER ARG ARG PRO ARG PHE THR SEQRES 21 A 276 GLU LEU LYS ALA GLN LEU SER THR ILE LEU GLU GLU GLU SEQRES 22 A 276 LYS LEU GLN HET VG8 A1687 40 HETNAM VG8 4-(1,4'-BIPIPERIDIN-1'-YL)-7-({5-CHLORO-2-[(2- HETNAM 2 VG8 METHOXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-2-METHYL-2, HETNAM 3 VG8 3-DIHYDRO-1H-ISOINDOL-1-ONE FORMUL 2 VG8 C30 H36 CL N7 O2 FORMUL 3 HOH *24(H2 O) HELIX 1 1 GLN A 418 GLU A 420 5 3 HELIX 2 2 SER A 461 GLN A 477 1 17 HELIX 3 3 LEU A 507 ARG A 514 1 8 HELIX 4 4 ASP A 519 LYS A 540 1 22 HELIX 5 5 ALA A 548 ARG A 550 5 3 HELIX 6 6 ASP A 564 SER A 568 5 5 HELIX 7 7 PRO A 585 MET A 589 5 5 HELIX 8 8 ALA A 590 ARG A 597 1 8 HELIX 9 9 THR A 600 MET A 617 1 18 HELIX 10 10 LYS A 627 GLY A 638 1 12 HELIX 11 11 PRO A 648 TRP A 659 1 12 HELIX 12 12 ARG A 668 GLN A 686 1 19 SHEET 1 AA 5 ILE A 422 GLU A 430 0 SHEET 2 AA 5 ASP A 435 MET A 442 -1 O VAL A 436 N ILE A 428 SHEET 3 AA 5 ALA A 448 LYS A 454 -1 O LEU A 449 N TYR A 441 SHEET 4 AA 5 TRP A 496 GLU A 500 -1 O ILE A 497 N LYS A 454 SHEET 5 AA 5 LEU A 486 ILE A 490 -1 N ILE A 487 O ILE A 498 SHEET 1 AB 3 GLY A 505 GLU A 506 0 SHEET 2 AB 3 VAL A 552 SER A 556 -1 N VAL A 554 O GLY A 505 SHEET 3 AB 3 CYS A 559 LEU A 562 -1 O CYS A 559 N SER A 555 SSBOND 1 CYS A 456 CYS A 459 1555 1555 2.03 CISPEP 1 ASN A 493 PRO A 494 0 -1.63 SITE 1 AC1 13 ILE A 428 ALA A 452 GLU A 500 LEU A 501 SITE 2 AC1 13 CYS A 502 THR A 503 GLU A 506 ASN A 551 SITE 3 AC1 13 LEU A 553 GLY A 563 ASP A 564 LEU A 567 SITE 4 AC1 13 SER A 568 CRYST1 44.523 44.887 66.435 90.00 95.42 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022460 0.000000 0.002131 0.00000 SCALE2 0.000000 0.022278 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015120 0.00000